Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
INTEGRATED PHARMACY RESEARCH AND PRACTICE
INTEGRATED PHARMACY RESEARCH AND PRACTICE is indexed in Web of Science (ESCI), DOAJ. Published by DOVE MEDICAL PRESS LTD.
Checked against the index lists dated .
ISSN 2230-5254Verify ISSN ↗
Publisher: DOVE MEDICAL PRESS LTD
Cost to publish: Checking DOAJ for article charges…
Not listed in: Scopus, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is INTEGRATED PHARMACY RESEARCH AND PRACTICE indexed in Scopus?
No — INTEGRATED PHARMACY RESEARCH AND PRACTICE is not currently indexed in Scopus.
What is the impact factor of INTEGRATED PHARMACY RESEARCH AND PRACTICE?
INTEGRATED PHARMACY RESEARCH AND PRACTICE is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. Scopus has not published a current CiteScore for this title.
How much does it cost to publish in INTEGRATED PHARMACY RESEARCH AND PRACTICE?
The publisher lists an article processing charge of about US$2,320 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes INTEGRATED PHARMACY RESEARCH AND PRACTICE and what is its ISSN?
INTEGRATED PHARMACY RESEARCH AND PRACTICE is published by DOVE MEDICAL PRESS LTD. Its ISSN is 2230-5254.
Is INTEGRATED PHARMACY RESEARCH AND PRACTICE in Web of Science?
Yes — indexed in the Emerging Sources Citation Index.
Is INTEGRATED PHARMACY RESEARCH AND PRACTICE open access?
Yes — it is an open-access journal, listed in DOAJ.
How well cited is INTEGRATED PHARMACY RESEARCH AND PRACTICE? — open metrics via OpenAlex
INTEGRATED PHARMACY RESEARCH AND PRACTICE has an h-index of 33 and a 2-year mean of 2.71 citations per paper (OpenAlex).
INTEGRATED PHARMACY RESEARCH AND PRACTICE published 13 papers in 2025; its busiest recent year was 2020 with 25. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-10-14.
Who publishes in INTEGRATED PHARMACY RESEARCH AND PRACTICE? — latest 86 articles, 2021–2026
In its latest 86 research articles (2021–2026), authors are most often from Ethiopia (21.5%), Sudan (15.5%) and Saudi Arabia (9.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for INTEGRATED PHARMACY RESEARCH AND PRACTICE? — indicators, not proof of misconduct
Scopus status: Not in the Scopus source list. 2 retracted papers are recorded (9.5 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusNot in the Scopus source list
- Retracted papers 2 · 9.5 per 1,000 papers
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.